Survey of Oncology Practitioners Prescribing XGEVA® in Europe to Evaluate Their Knowledge of XGEVA® Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw (20110102) First published 11/02/2014 Last updated 30/10/2015 EU PAS number:EUPAS5345 Study Finalised